Medical Oncology

Kevin Charles Oeffinger, MD

Professor of Medicine
Professor in the Department of Community and Family Medicine
Professor in Population Health Sciences
Member of the Duke Cancer Institute
Campus mail 2424 Erwin Dr, Suite 601, Duke Cancer Institute, Durham, NC 27705
Phone (919) 668-2122
Email address kevin.oeffinger@duke.edu

Kevin Oeffinger, MD, is a family physician, Professor in the Department of Medicine, and a member of the Duke Cancer Institute (DCI). He is founding Director of the DCI Center for Onco-Primary Care, and Director of the DCI Supportive Care and Survivorship Center. He has a long-standing track record of NIH-supported research in cancer screening and survivorship and has served in a leadership capacity in various cancer-focused and primary care-focused national committees and organizations, including the American Society of Clinical Oncology, the American Cancer Society, and the American Academy of Family Physicians. He is currently an Associate Editor for the Journal of the National Cancer Institute.

The three-fold mission of the DCI Center for Onco-Primary Care are are to: (1) deliver evidence-based, patient-centered, personalized health care across the cancer continuum by enhancing the interface between cancer specialists and primary care clinicians; (2) conduct innovative research with cutting-edge technology that can be translated to the community setting; and (3) train and educate the next generation of clinicians and researchers to extend this mission. 

Dr. Oeffinger's clinical expertise is managing survivors of pediatric and young adult cancer.

Education and Training

  • Advanced Research Training, Epidemiology And Genetics, Radiation Epidemiology, National Cancer Institute, 1999 - 2000
  • Family Medicine Academic Fellowship, Baylor College of Medicine, 1987 - 1988
  • Family Medicine Internship and Residency, Baylor College of Medicine, 1984 - 1987
  • M.D., University of Texas Health Science Center San Antonio, 1984

Grants

Publications

Dixon, Stephanie B., Eric J. Chow, Lars Hjorth, Melissa M. Hudson, Leontien C. M. Kremer, Lindsay M. Morton, Paul C. Nathan, Kirsten K. Ness, Kevin C. Oeffinger, and Gregory T. Armstrong. “The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress.” Pediatr Clin North Am 67, no. 6 (December 2020): 1237–51. https://doi.org/10.1016/j.pcl.2020.07.013.

PMID
33131544
Full Text

Ehrhardt, Matthew J., Zachary J. Ward, Qi Liu, Aeysha Chaudhry, Anju Nohria, William Border, Joy M. Fulbright, et al. “Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 38, no. 33 (November 2020): 3851–62. https://doi.org/10.1200/jco.20.00418.

PMID
32795226
Full Text

Blank, Peter de, Nan Li, Michael J. Fisher, Nicole J. Ullrich, Smita Bhatia, Yutaka Yasui, Charles A. Sklar, et al. “Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.” Genet Med 22, no. 11 (November 2020): 1794–1802. https://doi.org/10.1038/s41436-020-0873-7.

PMID
32572180
Full Text

Tonorezos, Emily S., Danielle Novetsky Friedman, Dana Barnea, Machteld I. Bosscha, Guillermo Chantada, Charlotte J. Dommering, Pim de Graaf, et al. “Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.” Ophthalmology 127, no. 11 (November 2020): 1549–57. https://doi.org/10.1016/j.ophtha.2020.05.024.

PMID
32422154
Full Text

Dixon, Stephanie B., Yan Chen, Yutaka Yasui, Ching-Hon Pui, Stephen P. Hunger, Lewis B. Silverman, Kirsten K. Ness, et al. “Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study.” J Clin Oncol 38, no. 29 (October 10, 2020): 3418–29. https://doi.org/10.1200/JCO.20.00493.

PMID
32706634
Full Text

Anderson, Nassim, Arash Delavar, Danielle Novetsky Friedman, Vijai Joseph, Nidha Mubdi, Kevin C. Oeffinger, Charles A. Sklar, et al. “Utilization of clinical genetic counseling among childhood and young adult cancer survivors in a registry trial.” J Community Genet 11, no. 4 (October 2020): 501–4. https://doi.org/10.1007/s12687-020-00478-0.

PMID
32676930
Full Text

Yeh, Jennifer M., Kathryn P. Lowry, Clyde B. Schechter, Lisa R. Diller, Oguzhan Alagoz, Gregory T. Armstrong, John M. Hampton, et al. “Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.” Ann Intern Med 173, no. 5 (September 1, 2020): 331–41. https://doi.org/10.7326/M19-3481.

PMID
32628531
Full Text

Shah, Anand, Thomas J. Polascik, Daniel J. George, John Anderson, Terry Hyslop, Alicia M. Ellis, Andrew J. Armstrong, et al. “Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network.” In Journal of General Internal Medicine, 2020. https://doi.org/10.1007/s11606-020-06124-2.

PMID
32875501
Full Text

Pages